FAMHP concludes EU GMP inspection at facility of Bharat Parenterals’ arm

28 Nov 2025 Evaluate

Federal Agency for Medicines and Health Products, Belgium (FAMHP) has completed the European Union Good Manufacturing Practice (EU GMP) inspection at Bharat Parenterals’ subsidiary -- Innoxel Lifesciences’ manufacturing facility. 

The inspection was carried out at the Innoxel Lifesciences’ manufacturing facility from November 24, 2025 to November 28, 2025. The audit was completed with zero critical and zero major observations, reflecting the company’s strong quality systems, robust manufacturing infrastructure, and strict adherence to global regulatory standards.

This milestone further strengthens the company’s regulatory credentials following its earlier successful USFDA inspection outcomes and reinforces its position as a trusted partner in regulated international markets.

Bharat Parenterals is engaged in to the business of the Pharmaceuticals & Drugs.

Bharat Parenterals Share Price

1094.90 -67.10 (-5.77%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×